Given the prevalence of depression in Parkinson's disease and the effectiveness of antidepressants, health care providers should promote adherence in clinical practice.
Previous research has found a higher prevalence of depression before and after an epilepsy diagnosis.
Escitalopram may be better for the treatment of depression than tDCS.
The longer women are exposed to estrogen during reproductive years, the less likely they are to be depressed.
Although there is currently no gold standard therapy for the treatment of fibromyalgia, a number of medications have shown modest efficacy in managing fibromyalgia-related pain, including pregabalin.
Overall, depression affects significantly more women than men.
Patients previously diagnosed with depression or anxiety did not have a greater risk of Alzheimer's.
Underlying pathophysiological mechanisms may connect depression and epilepsy.
A study aimed to clarify the relationship between anxiety and depression in patients with multiple sclerosis.
NMDA receptor signaling is increased in patients with depression and reduced in those with schizophrenia.
As dementia worsens, caregivers often have to report symptoms on behalf of the patient, and they tend to report more depressive symptoms than patients do.
Self-guided iCBT was more effective for depressive symptom severity and treatment response.
Among older adults with subthreshold depression, collaborative care was linked to a decrease in PHQ-9 scores.
Among ICH survivors, 63% developed both depression and dementia during a 5-year follow-up study.
Nearly half of seniors taking these drug combinations didn't have a formal diagnosis of a mental health condition, insomnia, or pain condition.
There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.
Comorbid psychological conditions affect cognitive function in Parkinson's disease, and treatment can be complicated by overlapping symptoms.
Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.
Varenicline and bupropion pose a lower risk of serious mental health side effects than was previously thought.
Prevalence of depression or depressive symptoms was 27.2% while suicide ideation was 11.1%.
Number of AEDs and seizure frequency also influenced depression in people with epilepsy.
Overall, 26 of the 34 studies suggested a positive relationship between insomnia and depression.
Time spent on mobile phones and social media may contribute to the rise in depression.
Patients with tension-type headaches had a significantly higher prevalence of anxiety and depression.
Effects of fetal exposure are yet to be determined.
Patients with type 2 diabetes and major depressive disorder spent a significant amount of time experiencing depressive episodes.
Nearly 80% of depressive symptoms occur within the first 6 months after TBI.
The risk is especially high in teens.
Dementia risk was elevated in those who had higher scores on cognitive tests at baseline.
New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.
Neurology Advisor Articles
- Case Series: New Chronic Headache Subtype Uncovered
- Parkinsonism Diagnosis Linked to Cognitive Deficits
- Dose "Ceiling" May Exist for Epilepsy Treated With Lamotrigine
- ENCHANTED Update: No Role for Low-Dose Alteplase After All?
- Amyotrophic Lateral Sclerosis Progression Associated With Changes in Immune Status
- Migraine and Gastrointestinal Disorders: Elucidating an Association
- Alzheimer's Disease Risk Similar in Women and Men With APOE ε3/ε4 Genotype
- Multiple Sclerosis Risk Significantly Associated With Vitamin D Deficiency
- FDA Approves Device for Tx of Chronic Pain
- FDA Approves Demyelinating Polyneuropathy Treatment
- Neuropathic Pain Linked to Vitamin Deficiency in Rheumatoid Arthritis
- Prognostic Models for Predicting Death and Dependency in Parkinson's
- Physician Salaries are Stagnant
- Model Helps Identify Seizure Risk in Critically Ill
- Antiepileptic Drugs Linked to Impaired Bone and Muscle Development in Children